Any which way you slice it currently Kev, we are in a market...

Any which way you slice it currently Kev, we are in a market that has a huge ''risk off'' attitude.

As much as we here all love IHL, the broader market probably still views it as a speccie biotech with no revenue. That being the case, not many are taking the plunge.
There is a distinct lack of buying pressure, the lack of volume and the multiple technical signals on the charts show that pretty clearly.

Even the last 2 announcements failed to generate any sustainable momentum, despite their quality. So what can you do? Sit back and wait, or buy when the market dips. We are in the midst of a bear market, which are very well known for choppy rallies and troughs, so save your pennies and pick up more when things look bad if you believe the narrative.

Good luck all